CKD Stock

CKD ROE

The Return on Equity (ROE) of CKD (6407.T) as of Aug 11, 2026 is 9.90 %. In the previous year, Return on Equity (ROE) was 6.46 % — a change of 53.33% (higher).

ROE

9.90 %

YoY

53.33%

Last updated:

In 2026, CKD's return on equity (ROE) was 9.90 %, a 53.33% increase from the 6.46 % ROE in the previous year.

Access this data via the Eulerpool API

CKD Stock analysis

What does CKD do? The CKD Corporation is a Japanese company based in Kitakyushu, Japan. It was founded in 1943 and has since grown into a globally operating corporation in the fields of automation technology, mechanical engineering, and products for industrial applications. CKD has a long history of manufacturing products for the automation industry, starting with components for pneumatic systems and expanding to include hydraulic, electric, and electronic products. The company offers a wide range of products and solutions for automation tasks, including sensors, control systems, drives, and valves. CKD operates in various industries, including automotive, electronics, mechanical engineering, and aviation, with subsidiaries in countries such as the USA, China, Taiwan, Singapore, Malaysia, and Thailand. Important business areas for CKD include the production of pneumatic components, systems, and equipment, as well as semiconductor manufacturing machines. The company also produces systems for use in airplanes, such as pressure regulators. In summary, CKD Corporation is a globally operating company with a wide range of products and a strong presence in various industries. It specializes in automation technology and provides products and solutions for industrial applications, particularly in the areas of pneumatics, semiconductor manufacturing, and aviation. CKD holds a strong position in all of these industries and is an important supplier of products and systems. CKD is one of the most popular companies on Eulerpool.

ROE Details

Decoding CKD's Return on Equity (ROE)

CKD's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing CKD's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

CKD's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in CKD’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about CKD stock

Return on Equity (ROE) of CKD is 9.90 % in 2026.

Return on Equity (ROE) of CKD changed from 6.46 % to 9.90 %, representing a 53.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) CKD since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s CKD with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — CKD

All Key Metrics — CKD